Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine, and ornithine analogs.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biochemistry

• Publication date

  1995-03-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00011A033PMID 7893672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of thrombin and trypsin by tripeptide aldehydes.

  2009cited by this paper
• Theory of macromolecule-ligand interactions

  1994cited by this paper
• Relocating a negative charge in the binding pocket of trypsin.

  1994cited by this paper
• 11B NMR spectroscopy of peptide boronic acid inhibitor complexes of alpha-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes.

  1993cited by this paper
• Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile.

  1993cited by this paper
• A player of many parts: the spotlight falls on thrombin's structure.

  1993cited by this paper
• The solution conformation of (D)Phe-Pro-containing peptides: implications on the activity of Ac-(D)Phe-Pro-boroArg-OH, a potent thrombin inhibitor.

  1993cited by this paper
• Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis.

  1993cited by this paper
• A transition state in pieces: major contributions of entropic effects to ligand binding by adenosine deaminase.

  1992cited by this paper
• Thrombolytic therapy of acute myocardial infarction. Keeping the unfulfilled promises.

  1992cited by this paper
• A High-Speed Data-Collection System for Large-Unit-Cell Crystals using an Imaging Plate as a Detector

  1992cited by this paper
• The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships

  1992cited by this paper
• Thrombolytic therapy of acute myocardial infarction. Keeping the unfulfilled promises.

  1992cited by this paper
• Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.

  1991cited by this paper
• Thrombin structure and function: why thrombin is the primary target for antithrombotics.

  1991cited by this paper
• Computational method for the design of enzymes with altered substrate specificity.

  1991cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991cited by this paper
• The selective inhibition of thrombin by peptides of boroarginine.

  1990cited by this paper
• Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates.

  1990cited by this paper
• Auto-indexing of Oscillation Images

  1990cited by this paper
• A simple model for solvation in mixed solvents. Applications to the stabilization and destabilization of macromolecular structures.

  1990cited by this paper
• Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediates

  1989cited by this paper
• Enzymes work by solvation substitution rather than by desolvation.

  1989cited by this paper
• The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment.

  1989cited by this paper
• Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.

  1988cited by this paper
• Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes.

  1988cited by this paper
• Structure of a tetrahedral transition state complex of alpha-chymotrypsin dimer at 1.8-A resolution.

  1987cited by this paper
• Calculation of the relative change in binding free energy of a protein-inhibitor complex.

  1987cited by this paper
• Serine protease mechanism: structure of an inhibitory complex of alpha-lytic protease and a tightly bound peptide boronic acid.

  1987cited by this paper
• Incorporation of fast Fourier transforms to speed restrained least‐squares refinement of protein structures

  1987cited by this paper
• The use of an imaging proportional counter in macromolecular crystallography

  1987cited by this paper
• Functional group contributions to drug-receptor interactions.

  1984cited by this paper
• Ab initio calculations of guanidinium-carboxylate interaction

  1984cited by this paper
• The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors

  1983cited by this paper
• On the attribution and additivity of binding energies.

  1981cited by this paper
• D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin.

  1979cited by this paper
• Serine proteases: structure and mechanism of catalysis.

  1977cited by this paper
• Benzene dimer: A polar molecule

  1975cited by this paper
• X-ray crystallographic study of boronic acid adducts with subtilisin BPN' (Novo). A model for the catalytic transition state.

  1975cited by this paper
• Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region.

  1973cited by this paper
• The crystal structure of benzene at — 3°C

  1958cited by this paper

• Trends on Potential Boron-containing Drugs by Advancements in Ligand-protein Crystals Complexes.

  2025cites this paper
• Novel inhibitors and activity-based probes targeting serine proteases

  2022cites this paper
• Visualization of Topological Pharmacophore Space with Graph Edit Distance

  2022cites this paper
• Sparse Topological Pharmacophore Graphs for Interpretable Scaffold Hopping

  2021cites this paper
• Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues.

  2021cites this paper
• Exploring Topological Pharmacophore Graphs for Scaffold Hopping

  2020cites this paper
• Azobenzene-containing photoswitchable proteasome inhibitors with selective activity and cellular toxicity.

  2017cites this paper
• Design of Serine Protease Inhibitors

  2015cites this paper
• Defining the Core Proteome of the Chloroplast Envelope Membranes

  2013cites this paper
• Development of novel chemical tools for proteasome biology & a new approach to 1-azaspirocyclic ring system

  2012cites this paper
• Boron containing compounds as protease inhibitors.

  2012cites this paper
• Proteasome structure, function, and lessons learned from beta-lactone inhibitors.

  2011cites this paper
• Aminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors.

  2011cites this paper
• Human trypsinogens in the pancreas and in cancer

  2010cites this paper
• A Statistical Survey on the Binding Constants of Covalently Bound Protein–Ligand Complexes

  2010cites this paper
• Upgrading a Natural Product: Inhibition of Human β‐Tryptase by Cyclotheonamide Analogues

  2010cites this paper
• SYNTHESIS AND BIOCHEMICAL STUDIES ON SULFATED MONOMERS OF LOW MOLECULAR WEIGHT LIGNINS

  2009cites this paper
• 2.15 – Peptidomimetic and Nonpeptide Drug Discovery: Receptor, Protease, and Signal Transduction Therapeutic Targets

  2007cites this paper
• Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

  2006cites this paper
• Photoswitch inhibitors of alpha-chymotrypsin--increased substitution and peptidic character in peptidomimetic boronate esters.

  2006cites this paper
• Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.

  2006cites this paper
• Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.

  2006cites this paper
• Proteasome inhibition as a new therapeutic principle in hematological malignancies.

  2006cites this paper
• Progress in the design of low molecular weight thrombin inhibitors

  2005cites this paper
• Proteasome inhibition as a therapeutic strategy for hematologic malignancies

  2005cites this paper
• Virtual Screening and Scaffold Hopping Based on GRID Molecular Interaction Fields

  2005cites this paper
• Synthesis of new boron analogues of cyclic carboxylic α-amino acids using ring-closing metathesis reactions

  2004cites this paper
• The development of proteasome inhibitors as anticancer drugs.

  2004cites this paper
• 1,3-Dipolar Cycloadditions of Azomethine Ylides to Alkenylboronic Esters. Access to Substituted Boron Analogues of β-Proline and 3-Hydroxypyrrolidines.

  2004cites this paper
• Docking and Scoring

  2003cites this paper
• Synthesis and evaluation of macrocyclic transition state analogue inhibitors for alpha-chymotrypsin.

  2003cites this paper
• Modifying Hydroxyapatite Nucleating Peptides to Form Novel Boron Ceramics

  2003cites this paper
• 29 – DESIGN OF PEPTIDOMIMETICS

  2003cites this paper
• Pharmaceutical biotechnology

  2002cites this paper
• The influence of residue 190 in the S1 site of trypsin‐like serine proteases on substrate selectivity is universally conserved

  2002cites this paper
• Mutagenesis and mechanism-based inhibition of Streptococcus pyogenes Glu-tRNAGln amidotransferase implicate a serine-based glutaminase site.

  2002cites this paper
• Therapeutic applications of serine protease inhibitors

  2002cites this paper
• Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase.

  2001cites this paper
• Boron Therapeutics on the Horizon

  2001cites this paper
• Glutamyl-gamma-boronate inhibitors of bacterial Glu-tRNA(Gln) amidotransferase.

  2001cites this paper
• Strategies for the inhibition of serine proteases

  2001cites this paper
• Review Strategies for the inhibition of serine proteases

  2001cites this paper
• Proteinase inhibitors and activators: strategic targets for therapeutic intervention

  2000cites this paper
• Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.

  2000cites this paper
• Thrombin Inhibitor Design: X-Ray and Solution Studies Provide a Novel P1 Determinant

  2000cites this paper
• Atomic Structures of Two Nitroxide Spin Labels Complexed with Human Thrombin: Comparison with Solution Studies

  2000cites this paper
• Generating consistent sets of thermodynamic and structural data for analysis of protein-ligand interactions

  2000cites this paper
• Secondary structure peptide mimetics: design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors.

  1999cites this paper
• Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.

  1999cites this paper
• Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.

  1999cites this paper
• 7-Azabicycloheptane carboxylic acid: a proline replacement in a boroarginine thrombin inhibitor.

  1999cites this paper
• Strategies and progress towards the ideal orally active thrombin inhibitor.

  1999cites this paper
• Design and synthesis of potent and selective 5,6-fused heterocyclic thrombin inhibitors.

  1999cites this paper
• Relating structure to thermodynamics: The crystal structures and binding affinity of eight OppA‐peptide complexes

  1999cites this paper
• Bound structures of novel P3-P1' beta-strand mimetic inhibitors of thrombin.

  1999cites this paper
• Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 2.

  1999cites this paper
• Synthetic inhibitors of thrombin and factor Xa: from bench to bedside.

  1999cites this paper
• Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.

  1999cites this paper
• Crystal structure of recombinant human tissue kallikrein at 2.0 Å resolution

  1998cites this paper
• Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.

  1998cites this paper
• Biochemical and crystallographic characterization of homologous non-peptidic thrombin inhibitors having alternate binding modes.

  1998cites this paper
• Thrombin inhibitor design.

  1998cites this paper
• Multiple binding mode of reversible synthetic thrombin inhibitors. A comparative structural analysis.

  1998cites this paper
• Cardiovascular chemotherapy: anticoagulants.

  1998cites this paper
• [Molecular similarity. 2. The structural basis of drug design].

  1998cites this paper
• Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.

  1998cites this paper
• MOLEKULARE AHNLICHKEIT. 2. STRUKTURBASIERTER ENTWURF VON WIRKSTOFFEN

  1998cites this paper
• Oxyanion-mediated inhibition of serine proteases.

  1998cites this paper
• Chapter 8. Antithrombotics/Serine Proteases

  1997cites this paper
• Protein Crystallography in Medicine

  1997cites this paper
• Small-molecule direct thrombin inhibitors

  1997cites this paper
• The molecular environment of the Na+ binding site of thrombin.

  1997cites this paper
• Cardiovascular & Renal Small-molecule direct thrombin inhibitors

  1997cites this paper
• Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery.

  1997cites this paper
• New thrombin inhibitors in cardiovascular disease.

  1997cites this paper
• Rational design, synthesis, and serine protease inhibitory activity of a novel P1-argininal derivative featuring a conformationally constrained P2–P3 bicyclic lactam moiety

  1997cites this paper
• Active Site-directed Inhibitors of Rhodococcus 20 S Proteasome

  1997cites this paper
• Inhibition of dipeptidyl peptidase IV (CD26) by peptide boronic acid dipeptides.

  1997cites this paper
• New inhibitors of thrombin and other trypsin-like proteases: hydrogen bonding of an aromatic cyano group with a backbone amide of the P1 binding site replaces binding of a basic side chain.

  1997cites this paper
• Potentially Macrocyclic Peptidyl Boronic Acids as Chymotrypsin Inhibitors.

  1997cites this paper
• Design and synthesis of ring-constrained boropeptide thrombin inhibitors

  1996cites this paper
• Functionality map analysis of the active site cleft of human thrombin

  1996cites this paper
• Synthesis of conformationally-restricted boropeptide thrombin inhibitors

  1996cites this paper
• Structure-based understanding of ligand affinity using human thrombin as a model system.

  1996cites this paper
• Crystallographic determination of the structures of human α‐thrombin complexed with BMS‐186282 and BMS‐189090

  1996cites this paper
• Heparin enhances the catalytic activity of des-ETW-thrombin.

  1996cites this paper
• Engineering enzymes for stability.

  1996cites this paper
• Crystallographic determination of the structures of human alpha-thrombin complexed with BMS-186282 and BMS-189090.

  1996cites this paper
• Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human α‐thrombin

  1996cites this paper
• Direct Synthesis of [alpha-[(tert-Butoxycarbonyl)amino]alkyl]- boronates from (alpha-Haloalkyl)boronates.

  1996cites this paper
• Computational combinatorial ligand design: Application to human α-thrombin

  1996cites this paper